Terms: = Prostate cancer AND Ki-67 AND Diagnosis
68 results:
1. Curcumin inhibits prostate cancer by upregulating miR-483-3p and inhibiting UBE2C.
Li W; Wang F; Wang X; Xu W; Liu F; Hu R; Li S
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23645. PubMed ID: 38348716
[TBL] [Abstract] [Full Text] [Related]
2. Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women.
Jeanmard N; Bissanum R; Sriplung H; Charoenlappanit S; Roytrakul S; Navakanitworakul R
PLoS One; 2023; 18(11):e0291574. PubMed ID: 37922300
[TBL] [Abstract] [Full Text] [Related]
3. The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial.
Ahlin R; Nybacka S; Josefsson A; Stranne J; Steineck G; Hedelin M
Trials; 2022 Dec; 23(1):1041. PubMed ID: 36544211
[TBL] [Abstract] [Full Text] [Related]
4. Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates.
Cantley RL; Wang X; Reichert ZR; Chinnaiyan AM; Mannan R; Cao X; Spratt DE; Vaishampayan UN; Alumkal JJ; Morgan TM; Palapattu G; Davenport MS; Pantanowitz L; Mehra R
Cancer Cytopathol; 2023 Feb; 131(2):117-135. PubMed ID: 36264673
[TBL] [Abstract] [Full Text] [Related]
5. Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of prostate.
Thomas T; Wedden S; Afzal N; Mikel J; D'Arrigo C
Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):585-591. PubMed ID: 36083158
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: Histological features for accurate diagnosis and toward future novel therapies.
Ida A; Okubo Y; Kasajima R; Washimi K; Sato S; Yoshioka E; Osaka K; Suzuki T; Yamamoto Y; Yokose T; Kishida T; Miyagi Y
Pathol Res Pract; 2022 Jan; 229():153731. PubMed ID: 34952423
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
Bell PD; Huber AR; Agostini-Vulaj D
Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
[TBL] [Abstract] [Full Text] [Related]
8. Comparative study of immunohistochemical expression of ERG and MAGI2 in prostatic carcinoma.
Dawoud MM; Aiad HA; Bahbah AMNH; Shaban MI
Ann Diagn Pathol; 2021 Jun; 52():151727. PubMed ID: 33713943
[TBL] [Abstract] [Full Text] [Related]
9. [Immunohistochemical study of ki-67, p53 and Notch1 expressions in prostate cancer of different grades].
Kudryavtsev GY; Kudryavtseva LV; Mikhaleva LM; Solovieva NA; Babichenko II
Arkh Patol; 2020; 82(5):42-49. PubMed ID: 33054031
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features to distinguish malignant solitary fibrous tumors of the prostate from prostatic stromal tumors.
Xu Y; Li Z; Shi J; Fu Y; Zhu L; Fan X; Foo WC
Virchows Arch; 2021 Apr; 478(4):619-626. PubMed ID: 32820389
[TBL] [Abstract] [Full Text] [Related]
11. Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer.
Stopsack KH; Gerke T; Zareba P; Pettersson A; Chowdhury D; Ebot EM; Flavin R; Finn S; Kantoff PW; Stampfer MJ; Loda M; Fiorentino M; Mucci LA
Carcinogenesis; 2020 Jul; 41(7):904-908. PubMed ID: 32556091
[TBL] [Abstract] [Full Text] [Related]
12. An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer.
Brönimann S; Pradere B; Karakiewicz P; Abufaraj M; Briganti A; Shariat SF
Expert Rev Mol Diagn; 2020 Aug; 20(8):841-850. PubMed ID: 32552088
[TBL] [Abstract] [Full Text] [Related]
13. Photoirradiation after aminolevulinic acid treatment suppresses cancer cell proliferation through the HO-1/p21 pathway.
Nakayama T; Kobayashi T; Shimpei O; Fukuhara H; Namikawa T; Inoue K; Hanazaki K; Takahashi K; Nakajima M; Tanaka T; Ogura SI
Photodiagnosis Photodyn Ther; 2019 Dec; 28():10-17. PubMed ID: 31404677
[TBL] [Abstract] [Full Text] [Related]
14. Cystic metastasis of prostate cancer: A case report.
Zhang B; Bian B; Bi L; Wang Z; Zhao Y; Wang J
Medicine (Baltimore); 2018 Dec; 97(50):e13697. PubMed ID: 30558081
[TBL] [Abstract] [Full Text] [Related]
15. The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade prostate cancer: An
Mainta IC; Zilli T; Tille JC; De Perrot T; Vallée JP; Buchegger F; Garibotto V; Miralbell R
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1210-1218. PubMed ID: 29678527
[TBL] [Abstract] [Full Text] [Related]
16. Apparent diffusion coefficients in prostate cancer: correlation with molecular markers ki-67, HIF-1α and VEGF.
Ma T; Yang S; Jing H; Cong L; Cao Z; Liu Z; Huang Z
NMR Biomed; 2018 Mar; 31(3):. PubMed ID: 29315957
[TBL] [Abstract] [Full Text] [Related]
17. Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and diagnosis.
Grosset AA; Loayza-Vega K; Adam-Granger É; Birlea M; Gilks B; Nguyen B; Soucy G; Tran-Thanh D; Albadine R; Trudel D
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):558-563. PubMed ID: 29271792
[TBL] [Abstract] [Full Text] [Related]
18. [Clinical characteristics of 13 neuroendocrine prostate cancer patients].
Zhang WH; Si TG; Yang XL; Yang B; Liu CF; Yu HP; Xing WG; Guo Z
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1316-1319. PubMed ID: 28482433
[No Abstract] [Full Text] [Related]
19. Genomic tests to guide prostate cancer management following diagnosis.
Colicchia M; Morlacco A; Cheville JC; Karnes RJ
Expert Rev Mol Diagn; 2017 Apr; 17(4):367-377. PubMed ID: 28277880
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological study of 9 cases of prostate cancer involving the rectal wall.
Tang T; Yang Z; Zhang D; Qu J; Liu G; Zhang S
Diagn Pathol; 2017 Jan; 12(1):8. PubMed ID: 28095874
[TBL] [Abstract] [Full Text] [Related]
[Next]
